Data-driven quality improvement program to prevent hospitalisation and improve care of people living with coronary heart disease: Protocol for a process evaluation

Nashid Hafiz*, Karice Hyun, Qiang Tu, Andrew Knight, Charlotte Hespe, Clara K. Chow, Tom Briffa, Robyn Gallagher, Christopher M. Reid, David L. Hare, Nicholas Zwar, Mark Woodward, Stephen Jan, Emily R. Atkins, Tracey Lea Laba, Elizabeth Halcomb, Tracey Johnson, Timothy Usherwood, Julie Redfern

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

71 Downloads (Pure)


Background: Practice-level quality improvement initiatives using rapidly advancing technology offers a multidimensional approach to reduce cardiovascular disease burden. For the “QUality improvement in primary care to prevent hospitalisations and improve Effectiveness and efficiency of care for people Living with heart disease” (QUEL) cluster randomised controlled trial, a 12-month quality improvement intervention was designed for primary care practices to use data and implement progressive changes using “Plan, Do, Study, Act” cycles within their practices with training in a series of interactive workshops. This protocol aims to describe the systematic methods to conduct a process evaluation of the data-driven intervention within the QUEL study.

Methods: A mixed-method approach will be used to conduct the evaluation. Quantitative data collected throughout the intervention period, via surveys and intervention materials, will be used to (1) identify the key elements of the intervention and how, for whom and in what context it was effective; (2) determine if the intervention is delivered as intended; and (3) describe practice engagement, commitment and capacity associated with various intervention components. Qualitative data, collected via semi-structured interviews and open-ended questions, will be used to gather in-depth understanding of the (1) satisfaction, utility, barriers and enablers; (2) acceptability, uptake and feasibility, and (3) effect of the COVID-19 pandemic on the implementation of the intervention. 

Conclusion: Findings from the evaluation will provide new knowledge on the implementation of a complex, multi-component intervention at practice-level using their own electronic patient data to enhance secondary prevention of cardiovascular disease. Trial registration: Australian New Zealand Clinical Trials Registry (ANZCTR) number ACTRN12619001790134.

Original languageEnglish
Article number106794
JournalContemporary Clinical Trials
Publication statusPublished - Jul 2022


Dive into the research topics of 'Data-driven quality improvement program to prevent hospitalisation and improve care of people living with coronary heart disease: Protocol for a process evaluation'. Together they form a unique fingerprint.

Cite this